Christopher E. Pearson

Christopher E. Pearson

Auto-generated profile, based on publicly available information

Christopher E. Pearson

Department of Molecular Genetics, The Hospital for Sick Children, Genetics & Genome Biology, University of Toronto , Toronto, ON M5G 0A4

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
CPChristopher E. Pearson
Christopher E. Pearson
KEKerrie Nichol Edamura
Kerrie Nichol Edamura
JCJohn D. Cleary
John D. Cleary

1 March 2010 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
ACArturo López Castel
Arturo López Castel
JCJohn D. Cleary
John D. Cleary
CPChristopher E. Pearson
Christopher E. Pearson

2 February 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
FCfor the Biallelic Mismatch Repair Deficiency Consortium
for the Biallelic Mismatch Repair Deficiency Consortium
ASAdam Shlien
Adam Shlien
BCBrittany B Campbell
Brittany B Campbell
RBRichard de Borja
Richard de Borja
LALudmil B Alexandrov
Ludmil B Alexandrov
UTUri Tabori
Uri Tabori

1 August 2003 in Neuron
Verified
Journal Article
Closed access
PJPeng Jin
Peng Jin
DZDaniela C. Zarnescu
Daniela C. Zarnescu
FZFuping Zhang
Fuping Zhang
CPChristopher E. Pearson
Christopher E. Pearson
JLJohn C. Lucchesi
John C. Lucchesi
SWStephen T. Warren
Stephen T. Warren

1 April 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
KRKaalak Reddy
Kaalak Reddy
BZBita Zamiri
Bita Zamiri
SSSabrina Y.R. Stanley
Sabrina Y.R. Stanley
RMRobert B. Macgregor
Robert B. Macgregor
CPChristopher E. Pearson
Christopher E. Pearson
Certain DNA and RNA sequences can form G-quadruplexes, which can affect promoter activity, genetic instability, RNA splicing, translation, and neurite mRNA localization. Amyotrophic lateral sclerosis and frontotemporal dementia were recently shown to be caused by expansion of a (GGGGCC)n·(GGCCCC)n repeat in the C9orf72 gene. Mutant r(GGGGCC)n-containing transcripts aggregate in nuclear foci possibly sequestering repeat-binding proteins, suggesting a toxic RNA pathogenesis. We demonstrate that the r(GGGGCC)n RNA but not the C-rich r(GGCCCC)n RNA forms extremely stable uni- and multimolecular parallel G-quadruplex structures (up to 95 °C). Multimolecular G-quadruplex formation is influenced by repeat number and RNA concentration. MBNL1, a splicing factor that is sequestered in myotonic dystrophy patients by binding to expanded r(CUG)n repeat hairpins, does not bind the C9orf72 repeats, but the splicing factor ASF/SF2 can bind the r(GGGGCC)n repeat. Because multimolecular G-quadruplexes are enhanced by repeat length, RNA-RNA interactions facilitated by G-quadruplex formation at expanded repeats might influence transcript aggregation and foci formation in amyotrophic lateral sclerosis-frontotemporal dementia cells. Tract length-dependent G-quadruplex formation by the C9orf72 RNA should be considered when assessing the role of this repeat in C9orf72 gene activity, protein binding, transcript foci formation, and translation of the C9orf72 product, including the noncanonical repeat-associated non-ATG translation (RAN translation) into pathologic dipeptide repeats, as well as any oligonucleotide repeat-based therapy.

31 October 2013 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
RPRicardo Mouro Pinto
Ricardo Mouro Pinto
EDElla Dragileva
Ella Dragileva
AKAndrew Kirby
Andrew Kirby
ALAlejandro Lloret
Alejandro Lloret
ELEdith Lopez
Edith Lopez
VWVanessa C. Wheeler
Vanessa C. Wheeler
The Huntington's disease gene (HTT) CAG repeat mutation undergoes somatic expansion that correlates with pathogenesis. Modifiers of somatic expansion may therefore provide routes for therapies targeting the underlying mutation, an approach that is likely applicable to other trinucleotide repeat diseases. Huntington's disease HdhQ111 mice exhibit higher levels of somatic HTT CAG expansion on a C57BL/6 genetic background (B6.HdhQ111) than on a 129 background (129.HdhQ111). Linkage mapping in (B6x129).HdhQ111 F2 intercross animals identified a single quantitative trait locus underlying the strain-specific difference in expansion in the striatum, implicating mismatch repair (MMR) gene Mlh1 as the most likely candidate modifier. Crossing B6.HdhQ111 mice onto an Mlh1 null background demonstrated that Mlh1 is essential for somatic CAG expansions and that it is an enhancer of nuclear huntingtin accumulation in striatal neurons. HdhQ111 somatic expansion was also abolished in mice deficient in the Mlh3 gene, implicating MutLγ (MLH1–MLH3) complex as a key driver of somatic expansion. Strikingly, Mlh1 and Mlh3 genes encoding MMR effector proteins were as critical to somatic expansion as Msh2 and Msh3 genes encoding DNA mismatch recognition complex MutSβ (MSH2–MSH3). The Mlh1 locus is highly polymorphic between B6 and 129 strains. While we were unable to detect any difference in base-base mismatch or short slipped-repeat repair activity between B6 and 129 MLH1 variants, repair efficiency was MLH1 dose-dependent. MLH1 mRNA and protein levels were significantly decreased in 129 mice compared to B6 mice, consistent with a dose-sensitive MLH1-dependent DNA repair mechanism underlying the somatic expansion difference between these strains. Together, these data identify Mlh1 and Mlh3 as novel critical genetic modifiers of HTT CAG instability, point to Mlh1 genetic variation as the likely source of the instability difference in B6 and 129 strains and suggest that MLH1 protein levels play an important role in driving of the efficiency of somatic expansions. The expansion of a CAG repeat underlies Huntington's disease (HD), with longer CAG tracts giving rise to earlier onset and more severe disease. In individuals harboring a CAG expansion the repeat undergoes further somatic expansion over time, particularly in brain cells most susceptible to disease pathogenesis. Preventing this repeat lengthening may delay disease onset and/or slow progression. We are using mouse models of HD to identify the factors that modify the somatic expansion of the HD CAG repeat, as these may provide novel targets for therapeutic intervention. To identify genetic modifiers of somatic expansion in HD mouse models we have used both an unbiased genetic mapping approach in inbred mouse strains that exhibit different levels of somatic expansion, as well as targeted gene knockout approaches. Our results demonstrate that: 1) Mlh1 and Mlh3 genes, encoding components of the DNA mismatch repair pathway, are critical for somatic CAG expansion; 2) in the absence of somatic expansion the pathogenic process in the mouse is slowed; 3) MLH1 protein levels are likely to be a driver of the efficiency of somatic expansion. Together, our data provide new insight into the factors underlying the process of somatic expansion of the HD CAG repeat.